Boothbay Fund Management LLC Has $6.52 Million Stake in Option Care Health, Inc. (NASDAQ:OPCH)

Boothbay Fund Management LLC lifted its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 21.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 281,161 shares of the company's stock after buying an additional 49,588 shares during the period. Boothbay Fund Management LLC owned 0.17% of Option Care Health worth $6,523,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of OPCH. Cornerstone Investment Partners LLC boosted its stake in Option Care Health by 3.6% in the fourth quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company's stock valued at $221,000 after acquiring an additional 333 shares during the period. UMB Bank n.a. increased its position in Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after buying an additional 346 shares during the period. Assetmark Inc. lifted its stake in Option Care Health by 2.0% in the fourth quarter. Assetmark Inc. now owns 24,976 shares of the company's stock valued at $579,000 after buying an additional 487 shares during the last quarter. Pacer Advisors Inc. boosted its holdings in shares of Option Care Health by 2.2% during the fourth quarter. Pacer Advisors Inc. now owns 25,483 shares of the company's stock valued at $591,000 after acquiring an additional 537 shares during the period. Finally, Sheets Smith Wealth Management grew its position in shares of Option Care Health by 2.4% during the fourth quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company's stock worth $553,000 after acquiring an additional 550 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.

Option Care Health Price Performance

Shares of OPCH traded up $1.15 during midday trading on Friday, reaching $33.32. The stock had a trading volume of 1,255,243 shares, compared to its average volume of 1,818,175. The firm's 50 day moving average price is $33.34 and its 200-day moving average price is $28.83. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a market capitalization of $5.47 billion, a P/E ratio of 27.98, a P/E/G ratio of 2.30 and a beta of 1.07. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. Option Care Health's revenue was up 16.3% on a year-over-year basis. During the same period in the prior year, the company earned $0.26 EPS. On average, analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.64% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and upped their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Barrington Research reissued an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a report on Wednesday. JMP Securities reaffirmed a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. JPMorgan Chase & Co. increased their price target on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. Finally, Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $35.50.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.